US/UK/Canada

Share

Pick a time period -
Tags ( Active)

Carbiotix provides clarity on two previously communicated JCDA projects and how they will open new market opportunities

Carbiotix AB (publ) ("Carbiotix" or the “Company") provides additional clarity on two previously communicated Joint Commercial Development Agreement (JCDA) projects and how they will open new market opportunities. On 8th of December, Carbiotix announced it’s intention to sign two additional JCDAs before the end of the year. The first JCDA project will be with a leading global producer of oils from soya bean, serving multiple markets worldwide, and will provide a key substitute extract rich in fibre and protein. The second JCDA project will be with a technical partner, representing the Company’

Carbiotix accelerates JCDA timeline with leading date producer and provides a NutraCycle project update with one week of trading remaining

Carbiotix AB (publ) ("Carbiotix" or the “Company") announces today that the Company is accelerating the timeline of the Joint Commercial Development Agreement (JCDA) project with the global leader in date production, with whom an agreement was signed with on 11th of November. The Company also provides an update on the NutraCycle project, with one week of trading on Spotlight Stock Market remaining. Carbiotix and the date producer have agreed that the soluble fiber and protein rich extract from date pomace developed and scaled up by Carbiotix will be exhibited at Gulfood in Dubai between the

Carbiotix signs NutraCycle agreement with global beverage solutions provider

Carbiotix AB (publ) ("Carbiotix" or “the Company") announces today that the Company has signed a NutraCycle Joint Commercial Development Agreement (JCDA) with a global Business to-Business (B2B) beverage solutions provider operating in over 50 countries covering a range of grain, fruit and vegetable-based products. The JCDA will start already in Q4 2025 and continue over a 6-month period, following the successful completion of a laboratory pre-study project on two fruit and vegetable side-streams during 2025. The JCDA will include formulation verification with one or several Food & Beverage

Carbiotix signs NutraCycle agreement with top 10 global date producer

Carbiotix AB (publ) ("Carbiotix" or “the Company") announces today that the Company has signed a NutraCycle Joint Commercial Development Agreement (JCDA) with a top 10 global date producer able to generate up to 3,000 metric tons of a soluble fibre rich extract per annum using Carbiotix NutraCycle process. The JCDA will begin in Q4 2025 and continue over a 6-month period, and follows the successful completion of a laboratory pre-study project on date pomace in 2025. The JCDA include; (i) formulation verification with one or more Food & Beverage Consumer Packaged Goods (F&B CPG) companies (ii)

Carbiotix signs NutraCycle agreement with top 10 global wine producer

Carbiotix AB (publ) ("Carbiotix" or “the Company") announces today that the Company has signed a NutraCycle Joint Commercial Development Agreement (JCDA) with a top 10 global wine producer. The JCDA will start in Q4 2025 and continue over a 6-month period and follows the successful completion of a laboratory pre-study project on grape pomace during 2025. The value of the JCDA is 19,500 USD and will include formulation verification with one or several Food & Beverage Consumer Packaged Goods (F&B CPG) companies and engineering specification / investment case development. At the conclusion of

Carbiotix continues to add new NutraCycle projects in the third quarter

Carbiotix AB (publ) ("Carbiotix" or the “Company") announces today the Q3 2025 update of NutraCycle projects. Since June 30th, 2025, the total number of customer projects has increased by 8. Carbiotix now has a total of 61 customer projects. The Company added 9 new customer side-streams, bringing the total number of side-streams to 75. Additionally, Carbiotix continues with its ambition of starting five Joint Commercial Development Agreement (JCDA) projects in the second half of 2025. A JCDA project consists of two phases: (1) formulation validation with one or several F&B (Food & Beverage)

Carbiotix launches NutraCycle Formulation Lab service

Carbiotix AB (publ) ("Carbiotix" or “the Company") announces today the launch of its NutraCycle Formulation Lab service. The Formulation Lab service will be specifically directed towards food & beverage Consumer Packaged Goods (CPG) companies that do not process or have limited processing of plant-based materials but would like broad access to complex, low-cost upcycled soluble fibers, proteins and other bioactive ingredients to develop and expedite the launch of healthier and more sustainable processed food & beverage products.Erik Deaner, CEO of Carbiotix, comments:“I am very happy to

Carbiotix ramps up JDA project negotiations – update of NutraCycle projects

Carbiotix AB (publ) ("Carbiotix" or “the Company") announces today the Q2 2025 update of NutraCycle projects and notes a clear trend towards the signing of multiple Joint Development Agreement (JDA) projects in the second half of 2025. A JDA is a formal collaboration framework used in the NutraCycle service model. It typically follows a successful pre-study phase and outlines how Carbiotix and the partner— co-develop process engineering, product formulations, and go-to-market strategies. Since March 31st 2025, the total number of customer projects has increased by 6, reflecting an average

Carbiotix surpasses growth targets in Q1 - update of NutraCycle projects

Carbiotix AB (publ) ("Carbiotix" or “the Company") announces today the Q1 2025 update of NutraCycle projects, again surpassing growth targets. Since December 20th 2024, the total number of customer projects increased by 15, including Carbiotix’ first customer projects in South America. Carbiotix now has a total of 47 customer projects. The Company added 18 new customer side-streams and now has customer projects across 58 side-streams in total.Erik Deaner, CEO of Carbiotix, comments:Once again, I am very pleased with the growth in NutraCycle customer projects since Carbiotix last reported

Carbiotix receives signed Letter of Intent for first NutraCycle license agreement

Carbiotix AB (publ) ("Carbiotix" or the "Company") announces today that the Company has received a signed Letter of Intent (LOI) for its first NutraCycle license agreement. The LOI was signed by a leading Nordic and global plant-based dairy producer and outlines the requirements for moving forward with the signing of a NutraCycle license agreement. Business case modeling based on the customer’s side-stream (by-products from the company's manufacturing process) indicates up to 80% savings when manufacturing prebiotic extracts onsite compared to purchasing equivalent ingredients offsite.Erik

Carbiotix CEO reflects on 2024 and provides key milestones for 2025

Carbiotix AB (publ) ("Carbiotix" or “the Company") CEO Erik Deaner reflects on 2024 with regards to the strategic focus, sales & marketing, organization, and financials, and provides key milestones for 2025.Reflection of 2024“Now that 2024 has passed, I find it appropriate to reflect on the activities of this past year. 2024 was undoubtedly a transformative year for Carbiotix with the strategic decision to focus solely on the NutraCycle upcycling service. This decision was not only based on a thorough assessment of the Company’s strategic position in the marketplace, competitive

Carbiotix provides Q4 2024 update of ongoing NutraCycle projects

Carbiotix AB (publ) ("Carbiotix" or the "Company") announces today the Q4 2024 update regarding its ongoing NutraCycle projects. Since September 30th, the total number of customer projects doubled to 32 in total. Carbiotix added 16 new customer projects and its first customer projects in Asia. Customer projects now include 4 customers which each have annual revenues exceeding 10 billion USD. The Company added 21 new customer side-streams and now has customer projects across 40 side-streams in total.Erik Deaner, CEO of Carbiotix, comments:The increasing number of customer projects that we

Carbiotix provides Q3 2024 update of ongoing NutraCycle projects

Carbiotix AB (publ) ("Carbiotix" or “the Company") announces today an update for Q3 2024 regarding its ongoing NutraCycle projects as previously communicated. Since August 29th, the total number of customer projects increased by four, bringing the total to sixteen. The Company has added three laboratory pre-studies and one pilot pre-study. Carbiotix expanded its customer base with three new customer projects in Europe and its first customer project in Africa. Among these new customers are two companies with annual revenues exceeding 1 billion USD. Additionally, five new customer side-streams

Carbiotix initiates eight new NutraCycle pre-study projects and will begin quarterly reporting of new and ongoing customer projects

Carbiotix AB (publ) ("Carbiotix" or the "Company") announces today that the Company has initiated eight new NutraCycle pre-study projects and will begin quarterly reporting of both new and ongoing customer projects. The eight new projects are in addition to the two ongoing pre study projects and one joint development project previously communicated. This brings the total number of customer projects to eleven, with twelve different and side-stream products being examined. The Company attributes this rapid growth of NutraCycle projects to its recent participation at VitaFoods Europe in May and

Carbiotix completes metformin study and provides EU funding update

Carbiotix (publ) ("Carbiotix" or the "Company") announces today that the metformin study has now been completed after aligning with the project group. While the Polymerase Chain Reaction (PCR) results communicated on November 1st, 2023, indicated that 20% of patients in the intervention cohort responded positively to a prebiotic containing CarbiAXOS, experiencing an average improvement of 15% in HbA1c (blood glucose) levels and an upregulation of Short Chain Fatty Acid (SCFA) levels, the Next Generation Sequencing (NGS) results after bioinformatic analysis were inconclusive due to the study’s

The Board of Directors of Carbiotix AB (publ) proposes a directed share issue of a maximum of approximately SEK 7.00 million

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, HONG KONG, NEW ZEALAND, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, SINGAPORE, JAPAN, RUSSIA, BELARUS OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD NOT BE IN COMPLIANCE WITH APPLICABLE LAWS OR REGULATIONS OR WOULD REQUIRE REGISTRATION OR SIMILAR MEASURES. The Board of Directors of Carbiotix AB (publ) (“Carbiotix” or the “Company”) has today resolved to propose a directed share issue of a maximum of 175,000,024 shares at a

Carbiotix AB’s warrant exercise registered at the Swedish Companies Registration Office

Carbiotix AB ("Carbiotix" or "Company") today announces that the new shares from the exercise of warrants of series TO 3 have been registered with the Swedish Companies Registration Office.On 19 June 2024, the exercise period for warrants of series TO 3, which were issued in connection with Carbiotix’s rights issue of units earlier in 2024, ended. As a result of the warrant exercise, 20,796,181 new shares have now been registered with the Swedish Companies Registration Office. The total number of shares in the Company after the exercise of warrants of series TO 3 amounts to 201,022,976 and

Carbiotix AB announces the outcome of the exercise of warrants of series TO 3

On June 19, 2024, the exercise period for Carbiotix AB's ("Carbiotix" or "Company") warrants of series TO 3 ("TO 3") ended. In total, 20,796,181 warrants of series TO 3 have been exercised, corresponding to approximately 39 percent of the total number of warrants, which means that the Company receives approximately SEK 0.83 million before deductions for issue costs.During the period 5-19 June 2024, holders of warrants of series TO 3 have had the right to subscribe for shares with the support of warrants. One (1) warrant of series TO 3 gave the holder the right to subscribe for one (1) new

Carbiotix provides update of staff re-organisation

Carbiotix AB (publ) ("Carbiotix" or the "Company") has today provided an update of the staff re-organisation originally communicated on May 28th. Five individuals will be impacted by the re-organisation, including three full-time employees and two consultants. Included among these individuals are CIO Martin Erlandsson and CMO Richard Rosenbloom, who will thereby leave the management team of Carbiotix. At the same time, and as previously communicated, Carbiotix will be expanding its process engineering team to meet an increased demand for its NutraCycle service.Erik Deaner, CEO of Carbiotix,

The last day of trading in warrants of series TO 3 is on the 17th of June 2024

The 17th of June 2024 is the last day of trading in warrants of series TO 3, which were issued in connection with Carbiotix AB's ("Carbiotix" or the "Company") preferential rights issue of units that was carried out in January 2024. The exercise period runs until the 19th of June 2024.In connection with the Company's preferential rights issue of units carried out in January 2024, 53,163,522 warrants of series TO 3 were issued. Holders of TO 3 have the right to subscribe for one (1) new share in Carbiotix at a price of SEK 0.04 per share during the exercise period, which runs until June 19th,

The exercise period for warrants of series TO 3 commences today

Today is the first day for the exercise of Carbiotix AB's ("Carbiotix" or "Company") warrants of series TO 3 ("TO 3") which were issued in connection with the preferential issue of units the Company carried out earlier this year. The period lasts until June 19, 2024. Holders of TO 3 have the right to subscribe for one (1) new share in Carbiotix for each TO 3 at a price of SEK 0.04 per share. Through full use of TO 3, the Company can receive a maximum of approximately SEK 2.1 million before issue costs. An information document is available on the respective websites of Carbiotix (www.carbiotix.

The exercise price for warrants of series TO 3 has been set to SEK 0.04 per new share

Carbiotix AB ("Carbiotix" or "the Company") hereby announces that the exercise price for the warrants of series TO 3 (”TO 3”), which were issued in connection with the rights issue of units the Company executed earlier during 2024, has been set. The exercise price for TO 3 has been set to SEK 0.04 per share and the exercise period commences on June 5th, 2024.In January 2024, Carbiotix carried out a rights issue which brought the Company approximately SEK 11.2 million before issue costs. Through the rights issue, 53,163,522 warrants of series TO 3 were issued. Each TO 3 entitles the holder

Carbiotix announces strategic re-focus and staff re-organisation

Carbiotix (publ) ("Carbiotix" or the "Company") announces today that the company will implement a strategic re-focus after positive feedback from the VitaFoods tradeshow in Geneva. As a consequence, the Company will re-organise its staff. This re-organisation reflects a decision by the Board of Directors to focus on the growth of its NutraCycle service in the near to medium term. The people who will be affected by the re-organisation will be confirmed after contact is made with the appropriate union representatives. Carbiotix will also be expanding its process engineering team to meet an

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Subscribe

Media